PROEHL GERALD T - President, CEO and Chairman, Director, 10%+ Owner at Dermata Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
President, CEO and Chairman, Director, 10%+ Owner
Issuer Symbol
DRMA, DRMAW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by PROEHL GERALD T since 10 Feb 2025

Holdings reported by PROEHL GERALD T for Dermata Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 490,255 $1,485,472 $3.03 23 Dec 2025 By Proehl Family Trust
Common Stock 122,563 $371,365 $3.03 23 Dec 2025 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Common Stock 79,795 $241,778 $3.03 23 Dec 2025 By Proehl Investment Ventures LLC
Common Stock 24 $72 $3.03 23 Dec 2025 Direct
Common Stock 7 $21 $3.03 23 Dec 2025 By Allison Taylor Proehl 2020 Irrevocable Trust
Common Stock 3 $9 $3.03 23 Dec 2025 By Meghan Proehl Wilder 2020 Irrevocable Trust
Warrant (Right to Buy) 787,402 21 Jan 2025 By Proehl Investment Ventures LLC Common Stock
Series C Warrant (Right to Buy) 490,496 23 Dec 2025 By Proehl Family Trust Common Stock
Series D Warrant (Right to Buy) 490,496 23 Dec 2025 By Proehl Family Trust Common Stock
Series C Warrant (Right to Buy) 122,549 23 Dec 2025 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 Common Stock
Series D Warrant (Right to Buy) 122,549 23 Dec 2025 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 Common Stock
Warrant (Right to Buy) 78,740 23 Dec 2025 Direct Common Stock
Stock Option (right to buy) 37,500 02 Jan 2026 Direct Common Stock

Transactions reported by PROEHL GERALD T for Dermata Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.